data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Avidity Biosciences
(NASDAQ:RNA)
14.55
0.33[2.32%]
At close: Jun 27
14.55
00
After Hours: 4:01PM EDT
Day High/Low13.95 - 14.79
52 Week High/Low10.89 - 29.59
Open / Close14.22 / 14.55
Float / Outstanding40.8M / 49.8M
Vol / Avg.164K / 326.8K
Mkt Cap724.1M
P/E-
50d Avg. Price13.97
Div / Yield-
Payout Ratio-
EPS-0.71
Total Float40.8M

Avidity Biosciences (NASDAQ:RNA), Quotes and News Summary

Avidity Biosciences (NASDAQ: RNA)

Day High/Low13.95 - 14.79
52 Week High/Low10.89 - 29.59
Open / Close14.22 / 14.55
Float / Outstanding40.8M / 49.8M
Vol / Avg.164K / 326.8K
Mkt Cap724.1M
P/E-
50d Avg. Price13.97
Div / Yield-
Payout Ratio-
EPS-0.71
Total Float40.8M
Benzinga - May 11, 2022, 9:22AM
Benzinga - May 11, 2022, 5:05AM
Benzinga - May 10, 2022, 5:27PM
Benzinga - Apr 5, 2022, 9:07AM
Benzinga - Mar 1, 2022, 4:49PM
Benzinga - Dec 10, 2021, 11:07AM
Benzinga - Dec 10, 2021, 4:35AM
Benzinga - Nov 9, 2021, 5:08PM
Benzinga - Nov 4, 2021, 9:35AM
Benzinga - Oct 18, 2021, 9:15AM
Benzinga - Sep 7, 2021, 7:38AM
Benzinga - Sep 1, 2021, 12:32PM
Benzinga - Aug 30, 2021, 12:28PM
Benzinga - Aug 24, 2021, 8:36AM
Benzinga - Aug 16, 2021, 8:35AM
Benzinga - Aug 10, 2021, 8:44AM
Benzinga - Aug 9, 2021, 5:10PM
Benzinga - Aug 3, 2021, 1:06PM
load more
Sector: Health Care.Industry: Biotechnology
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-0.800-0.710 0.0900
REV1.900M1.795M-105.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Avidity Biosciences Questions & Answers

Q
How do I buy Avidity Biosciences (RNA) stock?
A

You can purchase shares of Avidity Biosciences (NASDAQ: RNA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Avidity Biosciences's (RNA) competitors?
Q
What is the target price for Avidity Biosciences (RNA) stock?
A

The latest price target for Avidity Biosciences (NASDAQ: RNA) was reported by Credit Suisse on Wednesday, May 11, 2022. The analyst firm set a price target for 32.00 expecting RNA to rise to within 12 months (a possible 119.93% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Avidity Biosciences (RNA)?
A

The stock price for Avidity Biosciences (NASDAQ: RNA) is $14.55 last updated June 27, 2022, 8:00 PM UTC.

Q
Does Avidity Biosciences (RNA) pay a dividend?
A

There are no upcoming dividends for Avidity Biosciences.

Q
When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?
A

Avidity Biosciences’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Avidity Biosciences (RNA) going to split?
A

There is no upcoming split for Avidity Biosciences.

Q
What sector and industry does Avidity Biosciences (RNA) operate in?
A

Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.